Plasma PN-1 concentration was higher in patients with advanced chronic liver disease than in healthy individuals (0.21 vs. 0 ng/ml, p = 0.0001), strongly increased with liver disease severity and portal hypertension, and was associated with 1-year mortality. This evidence concerns the gene SERPINE2 and portal hypertension.